Comparing pharmacologic mechanism of action for the vesicular monoamine transporter 2 (VMAT2) inhibitors valbenazine and deutetrabenazine in treating tardive dyskinesia: does one have advantages over the other?

被引：17
|
作者：
Stahl, Stephen M.
机构：
来源：
CNS SPECTRUMS | 2018年 / 23卷 / 04期
关键词：
MOTOR STRIATUM; METABOLITES; STOP;
D O I：
10.1017/S1092852918001219
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The two approved treatments for tardive dyskinesia both inhibit the vesicular monoamine transporter type 2 (VMAT2) yet have pharmacologic properties that distinguish one from the other. Knowing these differences may help optimize which treatment to select for individual patients. © Cambridge University Press 2018.
引用
收藏
页码：239 / 247
页数：9
相关论文
共 6 条
1